Professor Ikemoto Publishes on Genetic Modification Debate in Biopolitical Times
Professor Lisa Ikemoto published an op-ed in Biopolitical Times on the debate over the recently developed genetic modification technique called CRISPR/cas9. The potential ramifications of CRISPR's use to modify the genetic make-up of species, including humans, has spurred debate between those who wish to stop, pause, or "fast forward" research, she writes. Ikemoto examines the positions taken by various factions and calls for a more comprehensive response to issues raised by the new technology.
"While I support a moratorium and rigorous discussion, we need more than an ad hoc response," Ikemoto writes. "It is time to develop a participatory governance approach to the many issues that technologies like CRISPR raise."
Lisa Ikemoto teaches bioethics and health law courses at the UC Davis School of Law. She has written extensively on genetic and reproductive technology, the regulation of fertility and pregnancy, and race and gender disparities in health care. Her current work examines emerging issues in regenerative medicine, including stem cell research, and the human tissues market.